Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...

“Our goal is really to get out all the cancer,” says Dr. Arvind Bakhru. In the operating room, the gynecologic oncologist relies on sight and feel to help identify the cancerous lesions he’ll remove.

Aug 15 (Reuters) - An experimental blood test detects early-stage ovarian cancer in patients with vague symptoms that would likely be misdiagnosed using currently available methods, researchers said ...